Skip to main content

Table 1 Characteristics of subjects in the sample

From: Body adiposity index in assessing the risk of type 2 diabetes mellitus development: the Baependi Heart Study

Variables

Cycle 1

Cycle 2

Diabetes free

Incident diabetes

p-value

n

1121

1046

75

–

Age, years

42.1 ± 16.1

46.9 ± 15.9

49.3 ± 16.6

0.24

Sex (% men)

44

43

47

< 0.001

Hypertension (%)

30

37

75

< 0.001

Increased WC (%)

30

42

61

< 0.001

Dyslipidaemia treatment (%)

3

7

24

< 0.001

SBP, mmHg

125.0 ± 18.5

125.2 ± 16.4

133.4 ± 17.8

< 0.001

DBP, mmHg

78.2 ± 11.2

76.7 ± 10.6

76.9 ± 10.3

0.88

BMI, kg/m2

24.3 ± 4.7

25.64 ± 4.9

28.45 ± 5.9

< 0.001

WC, cm

86.6 ± 11.79

90.6 ± 11.8

99.1 ± 11.6

< 0.001

Fasting glucose, mg/dL

87.5 ± 16.7

89.3 ± 10.2

137.3 ± 49.7

< 0.001

Total cholesterol, mg/dL

178.1 ± 46.9

200.6 ± 67.2

206.7 ± 51.9

0.33

HDL-cholesterol, mg/dL

56.4 ± 15.7

47.5 ± 11.8

46.2 ± 11.2

0.33

LDL-cholesterol, mg/dL

96.4 ± 42.8

125.3 ± 34.8

121.6 ± 44.9

0.51

Triglycerides, mg/dL

128.9 ± 68.9

123.8 ± 94.8

115.7 ± 78.6

0.39

  1. Hypertension: systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg and/or anti-hypertensive drug use. Dyslipidaemia treatment: percentage of individuals who used at least one class of lipid-lowering drug. Increased WC: ≥ 88 cm for women and ≥ 102 cm for men. Continuous data are expressed as the mean ± standard deviation and categorical data are expressed as percentage
  2. SBP, systolic blood pressure; DBP, diastolic blood pressure; BAI, body adiposity index; BMI, body mass index; WC, waist circumference
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us